BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3326594)

  • 1. [Induction of class-I MHC antigens on myocytes after heart transplantation: the pathomechanisms of the rejection reaction].
    Wonigeit K; Steinhoff G; Haverich A; Schäfers HJ; Wahlers T; Kemnitz J
    Beitr Infusionther Klin Ernahr; 1987; 18():335-7. PubMed ID: 3326594
    [No Abstract]   [Full Text] [Related]  

  • 2. MHC antigen expression in sequential biopsies from cardiac transplant patients--correlation with rejection.
    Suitters A; Rose M; Higgins A; Yacoub MH
    Clin Exp Immunol; 1987 Sep; 69(3):575-83. PubMed ID: 3311497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast of mediators: identification of cells and cytokines in human heart tissue with acute rejection and myocarditis.
    Zerbe TR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):443-4. PubMed ID: 2650171
    [No Abstract]   [Full Text] [Related]  

  • 4. Rejection of the transplanted heart.
    Murdock DK; Collins EG; Lawless CE; Molnar Z; Scanlon PJ; Pifarre R
    Heart Lung; 1987 May; 16(3):237-45. PubMed ID: 3553082
    [No Abstract]   [Full Text] [Related]  

  • 5. Sequential infiltration of class I and class II specific alloreactive T cells in human cardiac allografts.
    Duquesnoy RJ; Zeevi A; Fung JJ; Kaufman C; Zerbe TR; Griffith B; Trento A; Kormos R; Hardesty R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2560-3. PubMed ID: 3547938
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of donor major histocompatibility complex antigen expression in rat heart grafts and a model of chronic vascular rejection.
    Forbes RD; Darden AG; Gomersall M; Guttman RD
    Transplant Proc; 1989 Feb; 21(1 Pt 1):447-8. PubMed ID: 2650173
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of class I and class II antigens during rejection of allografted human hearts.
    Rose ML; Coles MI; Griffin RJ; Yacoub MH
    Adv Exp Med Biol; 1985; 186():555-63. PubMed ID: 3901688
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis of human cardiac allograft rejection by serial cardiac biopsy.
    Caves PK; Stinson EB; Billingham ME; Rider AK; Shumway NE
    J Thorac Cardiovasc Surg; 1973 Sep; 66(3):461-6. PubMed ID: 4582104
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular and molecular mechanisms of human cardiac myocyte injury after transplantation.
    Ansari AA; Sundstrom JB; Kanter K; Mayne A; Villinger F; Gravanis MB; Herskowitz A
    J Heart Lung Transplant; 1995; 14(1 Pt 1):102-12. PubMed ID: 7727458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electric myocardial impedance registration in humoral rejection after heart transplantation.
    Grauhan O; Müller J; Knosalla C; Cohnert T; Siniawski H; Volk HD; Fietze E; Kupetz W; Hetzer R
    J Heart Lung Transplant; 1996 Feb; 15(2):136-43. PubMed ID: 8672516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of surveillance biopsies in infant heart transplant recipients.
    Balzer DT; Moorhead S; Saffitz JE; Huddleston CB; Spray TL; Canter CE
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1095-101. PubMed ID: 8719456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA mismatching and outcome in heart, heart-lung, and single lung transplantation.
    Keogh A; Kaan A; Doran T; Macdonald P; Bryant D; Spratt P
    J Heart Lung Transplant; 1995; 14(3):444-51. PubMed ID: 7654729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex class I and class II expression by myocytes in cardiac biopsies posttransplantation.
    Ahmed-Ansari A; Tadros TS; Knopf WD; Murphy DA; Hertzler G; Feighan J; Leatherbury A; Sell KW
    Transplantation; 1988 May; 45(5):972-8. PubMed ID: 3285544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation.
    White JA; Guiraudon C; Pflugfelder PW; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1052-6. PubMed ID: 8719450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation.
    Stuart FP
    Conn Med; 1984 Dec; 48(12):801-4. PubMed ID: 6391807
    [No Abstract]   [Full Text] [Related]  

  • 17. Timing of the first endomyocardial biopsy in heart transplantation after induction immunosuppressive therapy--experience from Canadian Heart Transplant Centre.
    Málek F; Kaan A; Straatman L; Cheung A; Gnaszewski A
    Cas Lek Cesk; 2005; 144(8):507-9; discussion 509. PubMed ID: 16173602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic validity of hepatocyte growth factor as marker for rejection in the follow-up of patients after heart transplantation.
    Zwirska-Korczala K; Zakliczyński M; Berdowska A; Zembala M; Jochem J; Gajewska K
    J Heart Lung Transplant; 2005 Apr; 24(4):411-5. PubMed ID: 15797741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoimmunological monitoring to detect rejection after heart transplantation.
    Jutte NH; Daane R; van den Bemd JM; Hop WC; Essed CE; Simoons ML; Bos E; Weimar W
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2519-20. PubMed ID: 2650319
    [No Abstract]   [Full Text] [Related]  

  • 20. Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipients.
    van Gelder T; Mulder AH; Balk AH; Mochtar B; Hesse CJ; Baan CC; Vaessen LM; Weimar W
    J Heart Lung Transplant; 1995; 14(2):346-50. PubMed ID: 7779855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.